221 related articles for article (PubMed ID: 35820466)
1. NADH-Cytochrome B5 reductase 2 suppresses retinal vascular dysfunction through regulation of vascular endothelial growth factor A in diabetic retinopathy.
Chen J; Sun Y; Chen L; Zhou Y
Exp Eye Res; 2022 Sep; 222():109186. PubMed ID: 35820466
[TBL] [Abstract][Full Text] [Related]
2. MiR-203a-3p inhibits retinal angiogenesis and alleviates proliferative diabetic retinopathy in oxygen-induced retinopathy (OIR) rat model via targeting VEGFA and HIF-1α.
Han N; Xu H; Yu N; Wu Y; Yu L
Clin Exp Pharmacol Physiol; 2020 Jan; 47(1):85-94. PubMed ID: 31408201
[TBL] [Abstract][Full Text] [Related]
3. [Wogonoside alleviates high glucose-induced dysfunction of retinal microvascular endothelial cells and diabetic retinopathy in rats by up-regulating SIRT1].
Shao X; Yu J; Ni W
Nan Fang Yi Ke Da Xue Xue Bao; 2022 Apr; 42(4):463-472. PubMed ID: 35527482
[TBL] [Abstract][Full Text] [Related]
4. In vitro protective effect of miR-181d-5p in high glucose‑induced human retinal microvascular endothelial cells by targeting the angiogenic factor VEGFA.
Wang F; Yu C
Eur Rev Med Pharmacol Sci; 2022 Sep; 26(17):6199-6207. PubMed ID: 36111920
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of histone deacetylase SIRT1 exerts an antiangiogenic role in diabetic retinopathy via miR-20a elevation and YAP/HIF1α/VEGFA depletion.
Pan Q; Gao Z; Zhu C; Peng Z; Song M; Li L
Am J Physiol Endocrinol Metab; 2020 Nov; 319(5):E932-E943. PubMed ID: 32776826
[TBL] [Abstract][Full Text] [Related]
6. A novel regulatory network of linc00174/miR-150-5p/VEGFA modulates pathological angiogenesis in diabetic retinopathy.
Wang JJ; Wu KF; Wang DD
Can J Physiol Pharmacol; 2021 Nov; 99(11):1175-1183. PubMed ID: 34081870
[TBL] [Abstract][Full Text] [Related]
7. Genipin ameliorates diabetic retinopathy via the HIF-1α and AGEs-RAGE pathways.
Sun K; Chen Y; Zheng S; Wan W; Hu K
Phytomedicine; 2024 Jul; 129():155596. PubMed ID: 38626646
[TBL] [Abstract][Full Text] [Related]
8. Downregulation of glycoprotein non-metastatic melanoma protein B prevents high glucose-induced angiogenesis in diabetic retinopathy.
Qin T; Xi X; Wu Z
Mol Cell Biochem; 2023 Apr; 478(4):697-706. PubMed ID: 36036335
[TBL] [Abstract][Full Text] [Related]
9. TPTEP1 suppresses high glucose-induced dysfunction in retinal vascular endothelial cells by interacting with STAT3 and targeting VEGFA.
Sun X; Lu Y; Lei T
Acta Diabetol; 2021 Jun; 58(6):759-769. PubMed ID: 33576890
[TBL] [Abstract][Full Text] [Related]
10. Preliminary research on LncRNA ATP2B2-IT2 in neovascularization of diabetic retinopathy.
Yuan Y; Zhu A; Zeng L; Wang X; Zhang Y; Long X; Wu J; Ye M; He J; Tan W
BMC Ophthalmol; 2024 Jun; 24(1):267. PubMed ID: 38907191
[TBL] [Abstract][Full Text] [Related]
11. Circular RNA COL1A2 promotes angiogenesis via regulating miR-29b/VEGF axis in diabetic retinopathy.
Zou J; Liu KC; Wang WP; Xu Y
Life Sci; 2020 Sep; 256():117888. PubMed ID: 32497630
[TBL] [Abstract][Full Text] [Related]
12. Chlorogenic acid attenuates diabetic retinopathy by reducing VEGF expression and inhibiting VEGF-mediated retinal neoangiogenesis.
Mei X; Zhou L; Zhang T; Lu B; Sheng Y; Ji L
Vascul Pharmacol; 2018 Feb; 101():29-37. PubMed ID: 29146180
[TBL] [Abstract][Full Text] [Related]
13. Attenuation of streptozotocin-induced diabetic retinopathy with low molecular weight fucoidan via inhibition of vascular endothelial growth factor.
Yang W; Yu X; Zhang Q; Lu Q; Wang J; Cui W; Zheng Y; Wang X; Luo D
Exp Eye Res; 2013 Oct; 115():96-105. PubMed ID: 23810809
[TBL] [Abstract][Full Text] [Related]
14. Knockdown of Krüppel-Like Factor 9 Inhibits Aberrant Retinal Angiogenesis and Mitigates Proliferative Diabetic Retinopathy.
Han N; Zhang L; Guo M; Yu L
Mol Biotechnol; 2023 Apr; 65(4):612-623. PubMed ID: 36109428
[TBL] [Abstract][Full Text] [Related]
15. YAP1 is required for the angiogenesis in retinal microvascular endothelial cells via the inhibition of MALAT1-mediated miR-200b-3p in high glucose-induced diabetic retinopathy.
Han N; Tian W; Yu N; Yu L
J Cell Physiol; 2020 Feb; 235(2):1309-1320. PubMed ID: 31313295
[TBL] [Abstract][Full Text] [Related]
16. The mechanism of EGFL7 regulating neovascularization in diabetic retinopathy through the PI3K/AKT/VEGFA pathway.
Xian Y; Wang X; Yu Y; Chen X
Life Sci; 2024 Mar; 340():122483. PubMed ID: 38307238
[TBL] [Abstract][Full Text] [Related]
17. Protective effect of pentraxin 3 on pathological retinal angiogenesis in an in vitro model of diabetic retinopathy.
Jiang Y; Xing X; Niu T; Wang H; Wang C; Shi X; Liu K; Su L
Arch Biochem Biophys; 2022 Aug; 725():109283. PubMed ID: 35577071
[TBL] [Abstract][Full Text] [Related]
18. Long non-coding RNA MEG3 inhibits neovascularization in diabetic retinopathy by regulating microRNA miR-6720-5p and cytochrome B5 reductase 2.
Chen J; Liao L; Xu H; Zhang Z; Zhang J
Bioengineered; 2021 Dec; 12(2):11872-11884. PubMed ID: 34978518
[TBL] [Abstract][Full Text] [Related]
19. The mechanism by which crocetin regulates the lncRNA NEAT1/miR-125b-5p/SOX7 molecular axis to inhibit high glucose-induced diabetic retinopathy.
Chen Q; Xi X; Ma J; Wang X; Xia Y; Wang X; Deng Y; Li Y
Exp Eye Res; 2022 Sep; 222():109157. PubMed ID: 35718188
[TBL] [Abstract][Full Text] [Related]
20. Genipin relieves diabetic retinopathy by down-regulation of advanced glycation end products via the mitochondrial metabolism related signaling pathway.
Sun KX; Chen YY; Li Z; Zheng SJ; Wan WJ; Ji Y; Hu K
World J Diabetes; 2023 Sep; 14(9):1349-1368. PubMed ID: 37771331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
